Olaplex Reports Q3 2025 Revenue Decline and Increased Operating Expenses

Olaplex Holdings, Inc. reported a decline in financial performance for the third quarter of 2025, with net sales totaling $114.6 million, a decrease of 3.8% from $119.1 million in the same period last year. For the nine months ending September 30, 2025, net sales were $317.8 million, down 1.3% from $321.9 million in 2024. The company's gross profit margin improved slightly to 69.1% from 68.6% year-over-year, despite a decrease in total gross profit from $81.7 million to $79.2 million for the quarter. The decline in sales was attributed to a 13.5% drop in specialty retail sales, while professional sales increased by 5.3%.

Operating expenses surged significantly, rising 39.6% to $75.0 million in Q3 2025, primarily due to $9.3 million in acquisition-related costs from the purchase of Purvala Bioscience, Inc. The increase in selling, general, and administrative expenses was also driven by higher advertising and marketing costs, as well as payroll expenses. Consequently, operating income fell sharply to $4.2 million from $28.0 million in the prior year. The company reported a net income of $11.1 million for the quarter, down from $14.8 million in Q3 2024.

Olaplex's acquisition of Purvala, completed on August 20, 2025, for $10.5 million, was a significant strategic development during the quarter. This acquisition is expected to enhance the company's innovation pipeline in the health and beauty sectors. The transaction was classified as an asset acquisition, with the purchase price expensed due to the lack of alternative future use for the acquired in-process research and development technology.

In terms of operational metrics, the company reported a total cash and cash equivalents balance of $286.4 million as of September 30, 2025, down from $586.0 million at the end of 2024. The company also reduced its long-term debt significantly, from $643.7 million to $352.1 million, following a voluntary repayment of $300 million on its 2022 Term Loan Facility. This repayment was made using available cash and did not incur any prepayment penalties. The company maintains a liquidity position of $436.4 million, including $150 million available under its revolving credit facility.

Looking ahead, Olaplex is focused on enhancing brand demand through innovative marketing strategies and expanding its product offerings. The company is also monitoring macroeconomic conditions that could impact consumer spending and demand for its products. Despite the challenges faced in the current fiscal year, Olaplex aims to leverage its strong brand reputation and operational efficiencies to navigate the competitive landscape in the beauty industry.